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ABSTRACT 
A simple, sensitive and accurate RP-UPLC method has been developed for the determination of Linezolid in Tablet formulation. The mix of the 
Linezolid was found to be 251nm in Acetonitrile: Buffer [40:60(v/v)]. The method shows high sensitivity with linearity 5 to 3 0μg/ml 
(regression r2 = 0.999). This method was tested and validated for various parameters according to ICH guidelines and USP. The Detection limit 
and quantitation limit were found to be 50mg ml–1 and 150 mg ml–1 in Acetonitrile: Buffer [40:60(v/v)] respectively. The results 
demonstrated that the procedure is accurate, precise and reproducible (relative standard deviation < 2%), while being simple, cheap and less 
time consuming and can be suitably applied for the estimation of Linezolid in Tablet pharmaceutical formulation.  
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INTRODUCTION 
Analytical chemistry is a scientific discipline that develops 
methods, instruments and strategies to obtain information 
on the composition and nature of matter. Analytical 
chemistry is concerned with the chemical characterization of 
matter and thus pharmaceutical analysis covers matter 
having pharmaceutical applications. Knowledge of chemical 
composition of many substances is important in our daily 
life. Analytical chemistry plays an important role in nearly all 
aspects of chemistry viz. agricultural, clinical, environmental, 
forensic, manufacturing, metallurgical, and pharmaceutical 
chemistry.  
UPLC refers to Ultra Performance Liquid Chromatography. It 
improves in three areas: chromatographic resolution, speed 
and sensitivity analysis. It uses fine particles and saves time 
and reduces solvent consumption.  The UPLC is based on the 
principal of use of stationary phase consisting of particles 
less than 2 μm (while HPLC columns are typically filled with 
particles of 3 to 5 μm). The underlying principles of this 
evolution are governed by the van Demeter equation, which 
is an empirical formula that describes the relationship 
between linear velocity (flow rate) and plate height (HETP or 
column efficiency) 14. The Van Demeter curve governed by 
an equation with three components shows that the usable 
flow range for a good efficiency with small diameter particles 
is much greater than for larger diameters The advent of 
UPLC has demanded the development of a new instrumental 
system for liquid chromatography, which can take advantage 
of the separation performance (by reducing dead volumes) 
and consistent with the pressures (about 8000 to 15,000 PSI, 
compared with 2500 to 5000 PSI in HPLC). Efficiency is 
proportional to column length and inversely proportional to 
the particle size18. Therefore, the column can be shortened 
by the same factor as the particle size without loss of 
resolution. The application of UPLC resulted in the detection 
of additional drug metabolites, superior separation and 
improved spectral quality. 
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FigURE 1: Structure of Linezold 
 
Molecular Formula  : C16H20FN3O4  
Molecular Weight  : 337.346 g/mol 
IUPAC Name  :(S)-N-({3-[3-fluro-4-(morphine-4-
yl)phenyl1]-2-oxo-1,3xazolidi-5-yl}methyl)acetamide  
Description: white to off white powder 
Melting Point:  154°C  
Solubility: Linezolid is slightly soluble in acetone, and 
Insoluble in water, ethanol.  
Mode of action: Protein synthesis inhibitors 
Dose: 400mg / 600 mg  
Therapeutic Category:  Synthetic Antibacterial Agent of the 
oxazolidine class (Antibiotic) 
MATERIALS AND METHOD 
1. Instrument The liquid chromatographic system consisted 
of following components UPLC SYSTEM – TL/ARF/UPLC-05, 
Waters Acquity separation module PDA, Waters Empower 
Software-3. The chromatographic separation for Linezolid 
was carried out on a by using column ACQUITY UPLC ® HSS, 
1.8µ 2.150 mm. 
2. Reagents and materials Linezolid pure drug were 
obtained from Glenmark Generics Research Center, Taloja 
(Navi Mumbai) as a gift sample with 99.6% (w/w) assay 
value and was used without further purification. All 
chemicals and reagents used were of analytical grade 
(MERCK, RANKEM India). Linezolid tablets were purchased 
from local market and used with in self-life period. Each 
tablet was labeled contain 400mg of Linezolid. 
3. Chromatographic Conditions the mobile phase was 
prepared by dissolving 2.72gm of K2HPO4 and 2ml TEA in 
1000 ml water adjust pH 3.0 with OPA. From the previous 
solution, 600 ml was mixed with 400 ml of acetonitrile. Prior 
to use the mobile phase was filtered through 0.45 μm 
membrane filters and degassed by sonication for 10 min. the 
analysis was carried out on an UPLC Water Acquity system. 
The analytes were conducted on an analytical column 
ACQUITY UPLC ® HSS, 1.8µ 2.150 mm with a detection 
wavelength of 251 nm. The operating temperature of the 
column was set at 30°C. the injection volume was 0.5 μL, and 
the flow rate was maintained at 0.4 mL/min. the run time 
was 1.2 min. Column temperature 40°C0.   
4. Preparation of Linezolid standard solution: 
Weigh and transfer 30 mg of Linezolid working Standard into 
50 mL volumetric flask, add 30mL diluent and sonicate to 
dissolve. Dilute to volume with diluent and mix well. Further 
dilute 5.0 ml of the solution into 50ml volumetric flask 
(60ppm), dilute to volume with diluent and mix well. 
 5. Preparation of sample solution: 
Take a 5 tablet and crush. Weighed and transfer powder 
equivalent to 600 mg Linezolid in to 250mL volumetric flask, 
add 175mL diluent and sonicate this solution for about 15 
min. with intermediate shaking. Allow to stand this solution 
for 10 min. Makeup volume with diluent. Pipette out 5mL of 
this solution in to 200mL volumetric flask and make up to 
volume with diluents and mix. Filter the solution through 
0.45µ membrane filter and inject 
6. Preparation of Placebo Solution: Weighed and transfer 
placebo powder equivalent to 600 mg Linezolid in to 250mL 
volumetric flask, add 175mL diluent and sonicate this 
solution for about 15 min. with intermediate shaking. Allow 
to stand this solution for 10 min. Makeup volume with 
diluent. Pipette out 5mL of this solution in to 200mL 
volumetric flask and make up to volume with diluents and 
mix. Filter the solution through 0.45µ membrane filter and 
inject. 
 
 
Figure 2: Chromatogram of Linezolid 
Bhusnure et al                                                                                                Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):654-658 
ISSN: 2250-1177                                                                                   [656]                                                                                     CODEN (USA): JDDTAO 
Method Validation 
1. System suitability: 
The standard solution was injected five times into 
chromatograph & measured the area counts of Linezolid. 
The tailing factor of the main peak should be NMT 2.0.  
The theoretical plates of the main peak should be NLT 2000.  
The %RSD of the main peak area for five standard injections 
should be NMT 2.0%. 
2. Specificity:                              
The specificity of the method was determined by checking 
for interference with the drug from placebo components. 
This method was proven by the no change in absorbance of 
the drug with and without excipients at respective 
wavelength. Therefore, proposed method was specific and 
selective for the drug. 
3. Linearity and Range:   
A series of Standard preparations of Linezolid to be 
prepared over a range of 50% to 150% of the working 
concentration of Linezolid in Linezolid Tablet. (Minimum 
Five points should be in the range 80-120% of standard/ 
sample concentration for Assay). Since the working 
concentration is 100 µg per ml, of Linezolid, the range 
proposed is about 50 µg per ml to 150 µg per ml of Linezolid.  
 4. Accuracy (Recovery):  
Placebo of Linezolid will be spiked Linezolid with drug 
substance at three different levels: 80%, 100% and 120% of 
the label claim in triplicate (total nine determinations) and 
then to be prepared as described under Appendix A. Each of 
the sample preparations will be injected in duplicate and the 
average area count to be taken for calculation. Transfer 
accurately API and Placebo as given in the table below in 
volumetric flasks.  
 5. Precision: 
Method Precision: Six sample preparations of Linezolid 
Injections are to be prepared and injected into the UPLC 
using the method as described under Appendix A.  
 Ruggedness (Intermediate Precision) Six sample 
preparations of the same lot of Linezolid Injections is made 
by a different analyst, using different column on a different 
day and injected in duplicate into a different UPLC than 
using the method as described under Appendix A, along with 
Standard preparation. 
6. Robustness 
Robustness of the method was carried out by deliberately 
made small change in the Flow rate by ±10% (1.35 and 1.65 
ml/min), Column temperature by ±50C, Mobile phase 
composition by ±5% of ACN: Phosphate buffer (81:19, v/v 
and 79:21, v/v) and change in pH of Phosphate Buffer 
6.5±0.2 units had no significant effect on the retention time 
and chromatographic response of linezolid. 
Assay Method Validation Report 
UPLC method has been developed for the Assay of in 
Linezolid Tablet. This report is intended for the validation of 
UPLC method for the Assay of Linezolid in Linezolid Tablet 
Specificity 
Linearity and Range 
A series of Standard preparations of Linezolid to be 
prepared over a range of 50% to 150% of the working 
concentration of Linezolid in Linezolid Tablet. (Minimum 
Five points should be in the range 80-120% of standard/ 
sample concentration for Assay). Since the working 
concentration is 100 µg per ml, of Linezolid, the range 
proposed is about 50 µg per ml to 150 µg per ml of Linezolid.
 
Table 1: Linearity and Range 
 
% 
Concentration 
 
Concentration 
(µg per mL) 
 
Response 
(Area) 
 
Acceptance 
Criteria 
 
Statistical Analysis 
50% 30 228080 Correlation 
coefficient should 
not be less than 
0.999 
Slope 7515 
80% 48 364017 Intercept +2891 
100% 60 454183  
Correlation Coefficient 
 
1.000 120% 72 543428 
150% 90 679393 
 
 
Table 2: Calibration curve of Linezolid 
y = 7,515.4799x + 2,891.2069 
R² = 1.0000 
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Conclusion: Correlation coefficient is 1.000 Therefore, the UPLC method for the determination of Assay of Linezolid in 
Linezolid Tablet is linear. 
Accuracy (Recovery): 
Placebo of Linezolid were spiked with Linezolid drug substance at three different levels: 80%, 100%, 120% of the label claim in 
triplicate (total nine determinations) and then to be prepared as described under Methodology. Each of the sample 
preparation was injected in duplicate and average area count to be taken for calculation. 
Table 3: Accuracy data of the developed method 
Sample No. Amount Added 
(mg) 
Acceptance Criteria Amount Recovered 
(mg) 
% Recovery 
Acc. 80% -1 48.2 Mean recovery should be in 
the range of 98.0% to 
102.0%. The RSD should not 
more than 2.0% 
 
47.45 98.81 
Acc. 80% -2 48.2 47.45 98.81 
Acc. 100% -1 60.3 59.45 99.04 
Acc. 100% -2 60.3 59.45 99.04 
Acc. 120% -1 72.1 71.15 98.80 
Acc. 120% -2 72.1 71.15 98.80 
 Mean 98.88 
SD 0.134 
% RSD 0.135 
 
Conclusion: Mean recovery is 98.88% & RSD is 0.135%. Therefore, the UPLC method for the determination of Assay of 
Linezolid in Linezolid Tablet is accurate. 
Precision:  
Method Precision: 
Six sample preparation of Linezolid were prepared and injected into the UPLC using the method as described under 
Methodology. 
Table 4: Method Precision data 
Sample % Assay Acceptance Criteria Conclusion 
1 97.4  
 
 
 
 
 
RSD should not more 
than 2.0% 
 
The RSD of method 
precision is 0.52%. 
Therefore, the UPLC method 
for the determination of 
Assay of Linezolid Injection 
is reproducible. 
 
2 98.6 
3 98.2 
4 97.9 
5 98.6 
6 97.5 
Mean 98 
SD 0.51 
%RSD 0.52 
 
Sample % Assay Acceptance Criteria Conclusion 
1 97.4  
 
 
RSD should not more than 
2.0% 
 
The RSD of method 
precision is 0.75 %. 
Therefore, the UPLC 
method for the 
determination of Assay of 
Linezolid Injection is 
reproducible. 
 
2 98.6 
3 97.0 
4 98.2 
5 98.7 
6 97.8 
Mean 98.0 
SD 0.738 
%RSD 0.75 
 
Intermediate Precision: 
Six sample preparation of Linezolid were prepared and injected into the UPLC using the method as described under 
Methodology. 
Robustness:  
Robustness of the method was verified by applying minor and deliberate changes in the experimental parameters, for example: 
(i) Column temperature: ±5°C 
(ii) Flow rate: ±0.2 mL/min 
(iii) pH Variation (±0.2 units) 
(iv) Mobile phase composition, organic composition ±5% Change was made to evaluate its effect on the method. Obtained data 
for each case was evaluated by calculating % RSD and percent of recovery. 
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Table 5: Robustness data of the Developed Method Changed parameter 
Robustness data of the Developed 
Method Changed parameter  
Peak area / %RSD  Rt  Theoretical plates  Tailing factor  
Flow rate (±0.2%)  
0.6 ml/min  
0.2 ml/min  
 
454183± 0.3 
452552± 0.5  
 
0.452  
0.483 
 
28445  
24210 
 
1.04 
1.06  
Column temp (± 5°C) 
43°C   
38°C 
 
455692± 0.4 
487455± 0.7  
 
0.483 
0.447  
 
24432 
31268 
 
 
1.03 
1.08  
Mobile Phase (± 5%)  
65:35  
63:37  
 
465454± 0.8 
454154± 0.7  
 
0.486  
0.451 
 
28413 
24265  
 
1.12 
1.09  
pH Variation (±0.2 units) 
 6.3  
 6.7  
 
477682 ± 0.5  
465683 ± 0.4  
 
0.483 
0.489 
 
27478 
26410  
 
1.04 
1.18  
 
CONCLUSION 
Linezolid is Synthetic Antibacterial Agent of the oxazolidine 
class. It is official in United States Pharmacopoeia. The study 
was undertaken to develop and validate analytical methods 
to estimate Linezolid. 
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